-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Initiates Coverage On Opus Genetics with Market Outperform Rating, Announces Price Target of $12

Benzinga·04/28/2026 13:54:57
Listen to the news
Citizens analyst Jonathan Wolleben initiates coverage on Opus Genetics (NASDAQ:IRD) with a Market Outperform rating and announces Price Target of $12.